Figure 2.
CART or BsAb treatment-related adverse effects of interest with an incidence of ≥10% and ≥5%, respectively.

CART or BsAb treatment-related adverse effects of interest with an incidence of ≥10% and ≥5%, respectively.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal